Do Astrazeneca plc ADR (NASDAQ: AZN) Fit In A Value Investing Philosophy?
Currently, there are 3.10B common shares owned by the public and among those 3.10B shares have been available to trade. The company’s stock has a 5-day price change of -0.78% and -14.49% over the past three months. AZN shares are trading 0.32% year to date (YTD), with the 12-month market performance down to -5.52% lower. […]
Institutional Exposure To Astrazeneca plc ADR (AZN)
Astrazeneca plc ADR (AZN) concluded trading on Wednesday at a closing price of $66.58, with 3.88 million shares of worth about $258.17 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -14.37% during that period and on January 08, 2025 the price saw a […]
Astrazeneca plc ADR (NASDAQ: AZN) Loses -24.00% From High. Why That Could Change?
Currently, there are 3.10B common shares owned by the public and among those 3.10B shares have been available to trade. The company’s stock has a 5-day price change of 0.60% and -13.32% over the past three months. AZN shares are trading -1.07% year to date (YTD), with the 12-month market performance up to 0.50% higher. […]
Uncovering Institutional Buying In Astrazeneca plc ADR (NASDAQ: AZN)
Currently, there are 3.10B common shares owned by the public and among those 3.10B shares have been available to trade. The company’s stock has a 5-day price change of 0.00% and -14.51% over the past three months. AZN shares are trading -0.25% year to date (YTD), with the 12-month market performance up to 3.67% higher. […]
Investors Should Take Note Of Astrazeneca plc ADR (AZN)
Astrazeneca plc ADR (AZN) concluded trading on Wednesday at a closing price of $67.40, with 7.07 million shares of worth about $476.64 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -15.82% during that period and on December 11, 2024 the price saw a […]
Tomorrow Is Not Likely To Be Same For Astrazeneca plc ADR (AZN)
Astrazeneca plc ADR (AZN) concluded trading on Wednesday at a closing price of $66.78, with 5.07 million shares of worth about $338.28 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -16.86% during that period and on December 04, 2024 the price saw a […]
Astrazeneca plc ADR (NASDAQ: AZN): Hunting Genuine Value In Market Debris
Currently, there are 3.10B common shares owned by the public and among those 3.10B shares have been available to trade. The company’s stock has a 5-day price change of 5.91% and 1.94% over the past three months. AZN shares are trading -3.43% year to date (YTD), with the 12-month market performance down to -4.28% lower. […]
Analyst Expect Big Moves From Astrazeneca plc ADR (NASDAQ: AZN)
Currently, there are 3.10B common shares owned by the public and among those 3.10B shares have been available to trade. However, the script later moved the day high at 63.37, down -1.98%. The company’s stock has a 5-day price change of -5.15% and -2.00% over the past three months. AZN shares are trading -7.56% year […]
Handle With Care: Astrazeneca plc ADR (NASDAQ: AZN)
Currently, there are 3.10B common shares owned by the public and among those 3.10B shares have been available to trade. However, the script later moved the day high at 65.64, down -0.76%. The company’s stock has a 5-day price change of -3.05% and 1.50% over the past three months. AZN shares are trading -3.28% year […]
Astrazeneca plc ADR (AZN): Insights At A Glance
Astrazeneca plc ADR (AZN) concluded trading on Thursday at a closing price of $66.85, with 4.47 million shares of worth about $298.61 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -5.14% during that period and on Thursday, February 01 price saw a gain […]